SGBSYP LIMITEDActive

Company number 08063140Private limited companyIncorporated 2012

Key figures

£151,366-35.1%
Net assets 2024/25
+3.3%
Average annual growth 2020/21–2024/25
0100 k200 k300 k400 k2020/212021/222022/232023/242024/25

Like most small UK companies, SGBSYP LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0200 k400 k600 k2020/212021/222022/232023/242024/25
Filed accounts2020/21–2024/25
2020/212021/222022/232023/242024/25
Cash at bank and in hand158,26431,447264,623161,402286,738
Total assets303,425420,741497,660264,261354,451
Total liabilities———91,378247,498
Net assets / total equity132,700264,137342,389233,087151,366
Average number of employees58644

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: SGBSYP LIMITED

Company

SGBSYP LIMITED is a private limited company registered with Companies House under company number 08063140. It was incorporated on 9 May 2012. Its status is active. The registered office is in Corby (NN18). Its nature of business (SIC 2007) is dispensing chemist in specialised stores (47730), specialists medical practice activities (86220).

Accounts

The latest accounts in the database are for 2024/25 (period ending 31 Mar 2025); the company files small company accounts (filleted). Net assets were £151,366, down 35.1% on the previous year. Cash at bank and in hand was £286,738. Total assets were £354,451 and total liabilities £247,498. The company had an average of 4 employees. Figures are available for 5 financial years (2020/21–2024/25).

Control and charges

One person with significant control is registered. 2 of 3 registered charges are outstanding.

Filing deadlines

The next accounts are due by 31 Dec 2026. The next confirmation statement is due by 24 Feb 2027.